BACKGROUND: Estradiol activates endothelial nitric oxide synthase (eNOS) by mechanisms that involve estrogen receptor-alpha (ERalpha), protein kinase B/Akt, mitogen-activated protein kinases, and heat shock protein 90 (HSP90). Recently, AMP-activated protein kinase (AMPK), an enzyme that plays a crucial role in cellular adaptation to metabolic stress, has been implicated in physiological eNOS activation by the hormones adiponectin and insulin. We therefore investigated whether AMPK is activated by estradiol in endothelial cells and plays a role in estradiol-induced eNOS activation. METHODS AND RESULTS: Porcine aortic endothelial cells exhibited time- and concentration-dependent AMPK activation as determined by phosphorylation of AMPK and its downstream target acetyl coenzyme A carboxylase in response to estradiol (1 nmol/L to 10 micromol/L, 1 to 30 minutes). AMPK activation by estradiol was independent of both AMP levels and ERalpha but required estradiol conversion to its catechol metabolites. Estradiol treatment increased eNOS catalytic activity, an effect that was largely reversed when endothelial cells were infected with an AMPK dominant-negative adenovirus. However, inhibition of AMPK did not alter estradiol-induced eNOS phosphorylation at serine 1177 or threonine 495 but decreased eNOS interaction with HSP90. Consistent with this observation, blood vessels from alpha1-AMPK-null mice exhibited defective eNOS-mediated NO production in response to estradiol. CONCLUSIONS: Taken together, these data indicate that AMPK activity is essential for estradiol-induced eNOS activation via the promotion of eNOS interaction with HSP90. These data point to a novel role for AMPK in modulating endothelial cell NO bioactivity and HSP90 function.
BACKGROUND:Estradiol activates endothelial nitric oxide synthase (eNOS) by mechanisms that involve estrogen receptor-alpha (ERalpha), protein kinase B/Akt, mitogen-activated protein kinases, and heat shock protein 90 (HSP90). Recently, AMP-activated protein kinase (AMPK), an enzyme that plays a crucial role in cellular adaptation to metabolic stress, has been implicated in physiological eNOS activation by the hormones adiponectin and insulin. We therefore investigated whether AMPK is activated by estradiol in endothelial cells and plays a role in estradiol-induced eNOS activation. METHODS AND RESULTS: Porcine aortic endothelial cells exhibited time- and concentration-dependent AMPK activation as determined by phosphorylation of AMPK and its downstream target acetyl coenzyme A carboxylase in response to estradiol (1 nmol/L to 10 micromol/L, 1 to 30 minutes). AMPK activation by estradiol was independent of both AMP levels and ERalpha but required estradiol conversion to its catechol metabolites. Estradiol treatment increased eNOS catalytic activity, an effect that was largely reversed when endothelial cells were infected with an AMPK dominant-negative adenovirus. However, inhibition of AMPK did not alter estradiol-induced eNOS phosphorylation at serine 1177 or threonine 495 but decreased eNOS interaction with HSP90. Consistent with this observation, blood vessels from alpha1-AMPK-null mice exhibited defective eNOS-mediated NO production in response to estradiol. CONCLUSIONS: Taken together, these data indicate that AMPK activity is essential for estradiol-induced eNOS activation via the promotion of eNOS interaction with HSP90. These data point to a novel role for AMPK in modulating endothelial cell NO bioactivity and HSP90 function.
Authors: Daniel Bulut; Nadine Albrecht; Matthias Imöhl; Bülent Günesdogan; Nadine Bulut-Streich; Jan Börgel; Christoph Hanefeld; Michael Krieg; Andreas Mügge Journal: Clin Res Cardiol Date: 2007-02-26 Impact factor: 5.460
Authors: Eberhard Schulz; Jörn Dopheide; Swenja Schuhmacher; Shane R Thomas; Kai Chen; Andreas Daiber; Philip Wenzel; Thomas Münzel; John F Keaney Journal: Circulation Date: 2008-09-23 Impact factor: 29.690
Authors: Swenja Schuhmacher; Marc Foretz; Maike Knorr; Thomas Jansen; Marcus Hortmann; Philip Wenzel; Matthias Oelze; Andrei L Kleschyov; Andreas Daiber; John F Keaney; Gerhard Wegener; Karl Lackner; Thomas Münzel; Benoit Viollet; Eberhard Schulz Journal: Arterioscler Thromb Vasc Biol Date: 2011-01-04 Impact factor: 8.311
Authors: Guichun Han; Handong Ma; Rajesh Chintala; David J R Fulton; Scott A Barman; Richard E White Journal: J Pharmacol Exp Ther Date: 2009-03-17 Impact factor: 4.030
Authors: Angela Young; Wei Wu; Wei Sun; H Benjamin Larman; Harry B Larman; Nanping Wang; Yi-Shuan Li; John Y Shyy; Shu Chien; Guillermo García-Cardeña Journal: Arterioscler Thromb Vasc Biol Date: 2009-08-20 Impact factor: 8.311